Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information.

Journal of clinical pharmacy and therapeutics

Omaer A, Aldosari FM, McGlamery E, Alrashed S, Wool S, Fazel MT.
PMID: 34254331
J Clin Pharm Ther. 2021 Jul 12; doi: 10.1111/jcpt.13445. Epub 2021 Jul 12.

WHAT IS KNOWN AND OBJECTIVES: Migraine is a disabling disorder that affects individuals of all ages. To date, there are multiple limitations to using guidelines-recommended treatments and preventive therapies. The goal of this review was to provide a comprehensive...

Cite
Omaer A, Aldosari FM, McGlamery E, et al. Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. J Clin Pharm Ther. 2021;doi: 10.1111/jcpt.13445.
Omaer, A., Aldosari, F. M., McGlamery, E., Alrashed, S., Wool, S., & Fazel, M. T. (2021). Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. Journal of clinical pharmacy and therapeutics, . https://doi.org/10.1111/jcpt.13445
Omaer, Abubker, et al. "Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information." Journal of clinical pharmacy and therapeutics vol. (2021). doi: https://doi.org/10.1111/jcpt.13445
Omaer A, Aldosari FM, McGlamery E, Alrashed S, Wool S, Fazel MT. Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. J Clin Pharm Ther. 2021 Jul 12; doi: 10.1111/jcpt.13445. Epub 2021 Jul 12. PMID: 34254331.
Copy Download .nbib Format: NLM
Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information.

Journal of clinical pharmacy and therapeutics

Omaer A, Aldosari FM, McGlamery E, Alrashed S, Wool S, Fazel MT.
PMID: 34254331
J Clin Pharm Ther. 2021 Jul 12; doi: 10.1111/jcpt.13445. Epub 2021 Jul 12.

WHAT IS KNOWN AND OBJECTIVES: Migraine is a disabling disorder that affects individuals of all ages. To date, there are multiple limitations to using guidelines-recommended treatments and preventive therapies. The goal of this review was to provide a comprehensive...

Cite
Omaer A, Aldosari FM, McGlamery E, et al. Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. J Clin Pharm Ther. 2021;doi: 10.1111/jcpt.13445.
Omaer, A., Aldosari, F. M., McGlamery, E., Alrashed, S., Wool, S., & Fazel, M. T. (2021). Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. Journal of clinical pharmacy and therapeutics, . https://doi.org/10.1111/jcpt.13445
Omaer, Abubker, et al. "Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information." Journal of clinical pharmacy and therapeutics vol. (2021). doi: https://doi.org/10.1111/jcpt.13445
Omaer A, Aldosari FM, McGlamery E, Alrashed S, Wool S, Fazel MT. Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. J Clin Pharm Ther. 2021 Jul 12; doi: 10.1111/jcpt.13445. Epub 2021 Jul 12. PMID: 34254331.
Copy Download .nbib Format: NLM
Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information.

Journal of clinical pharmacy and therapeutics

Omaer A, Aldosari FM, McGlamery E, Alrashed S, Wool S, Fazel MT.
PMID: 34254331
J Clin Pharm Ther. 2021 Jul 12; doi: 10.1111/jcpt.13445. Epub 2021 Jul 12.

WHAT IS KNOWN AND OBJECTIVES: Migraine is a disabling disorder that affects individuals of all ages. To date, there are multiple limitations to using guidelines-recommended treatments and preventive therapies. The goal of this review was to provide a comprehensive...

Cite
Omaer A, Aldosari FM, McGlamery E, et al. Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. J Clin Pharm Ther. 2021;doi: 10.1111/jcpt.13445.
Omaer, A., Aldosari, F. M., McGlamery, E., Alrashed, S., Wool, S., & Fazel, M. T. (2021). Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. Journal of clinical pharmacy and therapeutics, . https://doi.org/10.1111/jcpt.13445
Omaer, Abubker, et al. "Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information." Journal of clinical pharmacy and therapeutics vol. (2021). doi: https://doi.org/10.1111/jcpt.13445
Omaer A, Aldosari FM, McGlamery E, Alrashed S, Wool S, Fazel MT. Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information. J Clin Pharm Ther. 2021 Jul 12; doi: 10.1111/jcpt.13445. Epub 2021 Jul 12. PMID: 34254331.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries